Foffano, L.; Bertoli, E.; Bortolot, M.; Torresan, S.; De Carlo, E.; Stanzione, B.; Del Conte, A.; Puglisi, F.; Spina, M.; Bearz, A.
Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches. Int. J. Mol. Sci. 2025, 26, 583.
https://doi.org/10.3390/ijms26020583
AMA Style
Foffano L, Bertoli E, Bortolot M, Torresan S, De Carlo E, Stanzione B, Del Conte A, Puglisi F, Spina M, Bearz A.
Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches. International Journal of Molecular Sciences. 2025; 26(2):583.
https://doi.org/10.3390/ijms26020583
Chicago/Turabian Style
Foffano, Lorenzo, Elisa Bertoli, Martina Bortolot, Sara Torresan, Elisa De Carlo, Brigida Stanzione, Alessandro Del Conte, Fabio Puglisi, Michele Spina, and Alessandra Bearz.
2025. "Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches" International Journal of Molecular Sciences 26, no. 2: 583.
https://doi.org/10.3390/ijms26020583
APA Style
Foffano, L., Bertoli, E., Bortolot, M., Torresan, S., De Carlo, E., Stanzione, B., Del Conte, A., Puglisi, F., Spina, M., & Bearz, A.
(2025). Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches. International Journal of Molecular Sciences, 26(2), 583.
https://doi.org/10.3390/ijms26020583
